Propofol infusion syndrome.
A review of the history, incidence, presentation, pathophysiology, and treatment of propofol infusion syndrome.
Wong
Jeremy M
JM
Department of Anesthesiology, David Geffen School of Medicine at UCLA, Ronald Reagan UCLA Medical Center, Los Angeles, CA 90095, USA. jeremywong@mednet.ucla.edu
D000138:Acidosis / Q000139:chemically induced / Q000503:physiopathology; D058186:Acute Kidney Injury / Q000139:chemically induced / Q000503:physiopathology; D018686:Anesthetics, Intravenous / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005260:Female; D006333:Heart Failure / Q000139:chemically induced / Q000503:physiopathology; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced / Q000503:physiopathology; D015228:Hypertriglyceridemia / Q000139:chemically induced / Q000503:physiopathology; D008297:Male; D015742:Propofol / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced / Q000503:physiopathology
D018686:Anesthetics, Intravenous; D015742:Propofol